These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19263232)

  • 1. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany.
    Kaatsch P; Reinisch I; Spix C; Berthold F; Janka-Schaub G; Mergenthaler A; Michaelis J; Blettner M
    Cancer Causes Control; 2009 Aug; 20(6):965-80. PubMed ID: 19263232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study.
    Guérin S; Hawkins M; Shamsaldin A; Guibout C; Diallo I; Oberlin O; Brugières L; de Vathaire F
    J Clin Oncol; 2007 Jul; 25(19):2833-9. PubMed ID: 17602088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and susceptibility to therapy-related myeloid neoplasms.
    Leone G; Fianchi L; Pagano L; Voso MT
    Chem Biol Interact; 2010 Mar; 184(1-2):39-45. PubMed ID: 20026017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D; Hanf V; Schulz T
    Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia incidence following primary breast carcinoma treatment.
    Kaplan HG; Malmgren JA; Atwood M
    Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
    Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
    J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary neoplasms after radiotherapy for a childhood solid tumor.
    Paulino AC; Fowler BZ
    Pediatr Hematol Oncol; 2005 Mar; 22(2):89-101. PubMed ID: 15804994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study.
    Guérin S; Guibout C; Shamsaldin A; Dondon MG; Diallo I; Hawkins M; Oberlin O; Hartmann O; Michon J; Le Deley MC; de Vathaire F
    Int J Cancer; 2007 Jan; 120(1):96-102. PubMed ID: 17013899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
    Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
    Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries.
    Svahn-Tapper G; Garwicz S; Anderson H; Shamsaldin A; De Vathaire F; Olsen JH; Døllner H; Hertz H; Jonmundsson G; Langmark F; Lanning M; Sankila R; Tulinius H; Möller T
    Acta Oncol; 2006; 45(4):438-48. PubMed ID: 16760180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia as a second malignancy.
    Uppin MS; Paul TR; Rajappa S; Gayathri K; Jacob R; Uppin SG
    Indian J Pathol Microbiol; 2007 Jul; 50(3):644-7. PubMed ID: 17883171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors.
    Peterson KM; Shao C; McCarter R; MacDonald TJ; Byrne J
    Pediatr Blood Cancer; 2006 Jul; 47(1):83-8. PubMed ID: 16317732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease.
    Hoppe RT
    Leukemia; 1992 Nov; 6 Suppl 4():155-7. PubMed ID: 1434819
    [No Abstract]   [Full Text] [Related]  

  • 16. Myelodysplastic syndrome and acute leukaemia following treatment of soft tissue sarcoma.
    de Graeff A; Vendrik CP; Pinedo HM
    Neth J Med; 1989 Jun; 34(5-6):251-7. PubMed ID: 2671758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
    Nguyen F; Rubino C; Guerin S; Diallo I; Samand A; Hawkins M; Oberlin O; Lefkopoulos D; De Vathaire F
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):908-15. PubMed ID: 18262102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H; Malmgren J; De Roos AJ
    Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary myelodysplastic syndrome after small cell lung cancer and esophageal cancer.
    Otsuka Y; Konishi T; Nara S; Furushima K; Nakajima K; Shimada H
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1318-21. PubMed ID: 16105115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of melanoma following adulthood cancer: a case-control study.
    Dupuy A; Shamsaldin A; Quiniou E; Paoletti C; Labbé M; Avril MF; Lefkopoulos D; de Vathaire F
    Eur J Cancer; 2005 Dec; 41(18):2904-10. PubMed ID: 16243516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.